Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T19:27:21.968Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:27:21.968Z.

Quote observation: 2026-10-06T19:25:15.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 2,333,019,360
TTM free cash flow · period ending 2026-05-31: -304,527,000

FMP input reference: 3dc852dbbee421fd1d0f2104bcbe090e37fdd8a7ae3294fdff0c13dff3b4c360

P/E Ratio|FCF Growth|Operating Margin|All Metrics

NRIX Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

PRICE/FCF RATIO AVG TTM

N/A

PRICE/FCF RATIO AVG 3Y

N/A

PRICE/FCF RATIO AVG 5Y

N/A

PRICE/FCF RATIO AVG 10Y

N/A

PRICE/FCF RATIO AVG 15Y

N/A

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NRIX Competitors' Price/FCF Ratio

NRIX

Nurix Therapeutics, Inc.

Current

Market Cap

$2.33B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

UFPT

UFP Technologies, Inc.

vs NRIX

Market Cap

$2.33B

Price/FCF Ratio

37.97

TTM Avg

25.12

3Y Avg

37.59

5Y Avg

73.49

ADMA

ADMA Biologics, Inc.

vs NRIX

Market Cap

$2.35B

Price/FCF Ratio

20.15

TTM Avg

65.29

3Y Avg

92.84

5Y Avg

92.84

LQDA

Liquidia Corporation

vs NRIX

Market Cap

$2.30B

Price/FCF Ratio

37.96

TTM Avg

109.25

3Y Avg

109.25

5Y Avg

109.25

IRON

Disc Medicine, Inc.

vs NRIX

Market Cap

$2.38B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HRMY

Harmony Biosciences Holdings, Inc.

vs NRIX

Market Cap

$2.28B

Price/FCF Ratio

6.43

TTM Avg

6.22

3Y Avg

8.21

5Y Avg

14.22

CLOV

Clover Health Investments, Corp.

vs NRIX

Market Cap

$2.40B

Price/FCF Ratio

32.37

TTM Avg

38.73

3Y Avg

40.68

5Y Avg

38.72

RXRX

Recursion Pharmaceuticals, Inc.

vs NRIX

Market Cap

$2.42B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALMR

Alamar Biosciences, Inc.

vs NRIX

Market Cap

$2.25B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SUPN

Supernus Pharmaceuticals, Inc.

vs NRIX

Market Cap

$2.46B

Price/FCF Ratio

131.17

TTM Avg

56.89

3Y Avg

28.15

5Y Avg

23.49

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Nurix Therapeutics, Inc. (NRIX)	$2.33B	N/A	N/A	N/A	N/A
UFP Technologies, Inc. (UFPT)vs ›	$2.33B	37.97	25.12	37.59	73.49
ADMA Biologics, Inc. (ADMA)vs ›	$2.35B	20.15	65.29	92.84	92.84
Liquidia Corporation (LQDA)vs ›	$2.30B	37.96	109.25	109.25	109.25
Disc Medicine, Inc. (IRON)vs ›	$2.38B	N/A	N/A	N/A	N/A
Harmony Biosciences Holdings, Inc. (HRMY)vs ›	$2.28B	6.43	6.22	8.21	14.22
Clover Health Investments, Corp. (CLOV)vs ›	$2.40B	32.37	38.73	40.68	38.72
Recursion Pharmaceuticals, Inc. (RXRX)vs ›	$2.42B	N/A	N/A	N/A	N/A
Alamar Biosciences, Inc. (ALMR)vs ›	$2.25B	N/A	N/A	N/A	N/A
Supernus Pharmaceuticals, Inc. (SUPN)vs ›	$2.46B	131.17	56.89	28.15	23.49

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

NRIX Price/FCF Ratio History

DATE	PRICE/FCF RATIO
2021-02-16	221.46
2021-02-12	214.25
2021-02-11	216.13
2021-02-10	213.86
2021-02-09	215.30
2021-02-08	212.03
2021-02-05	215.08
2021-02-04	200.33
2021-02-03	211.42
2021-02-02	219.74
2021-02-01	201.55
2021-01-29	201.77
2021-01-28	208.15
2021-01-27	218.02
2021-01-26	249.96
2021-01-25	256.84
2021-01-22	255.40
2021-01-21	244.03
2021-01-20	241.26
2021-01-19	278.25
2021-01-15	247.52
2021-01-14	236.54
2021-01-13	230.61
2021-01-12	227.45
2021-01-11	223.51
2021-01-08	223.18
2021-01-07	197.55
2021-01-06	172.10
2021-01-05	177.25
2021-01-04	180.64
2020-12-31	182.36
2020-12-30	195.78
2020-12-29	207.81
2020-12-28	226.50
2020-12-24	243.14
2020-12-23	251.13
2020-12-22	251.52
2020-12-21	199.66
2020-12-18	199.72
2020-12-17	243.53
2020-12-16	222.73
2020-12-15	242.20
2020-12-14	268.66
2020-12-11	220.29
2020-12-10	238.37
2020-12-09	228.72
2020-12-08	248.58
2020-12-07	242.31
2020-12-04	238.87
2020-12-03	244.03
2020-12-02	240.81
2020-12-01	238.93
2020-11-30	236.38
2020-11-27	217.63
2020-11-25	209.64
2020-11-24	214.69
2020-11-23	207.20
2020-11-20	208.76
2020-11-19	191.45
2020-11-18	189.51
2020-11-17	185.02
2020-11-16	177.92
2020-11-13	162.22
2020-11-12	161.28
2020-11-11	154.35
2020-11-10	139.21
2020-11-09	126.73
2020-11-06	128.62
2020-11-05	139.98
2020-11-04	139.10
2020-11-03	138.93
2020-11-02	139.32
2020-10-30	140.26
2020-10-29	145.09
2020-10-28	145.86
2020-10-27	159.17
2020-10-26	152.19
2020-10-23	157.07
2020-10-22	149.97
2020-10-21	149.25
2020-10-20	147.47
2020-10-19	147.19
2020-10-16	141.70
2020-10-15	135.10
2020-10-14	18.37
2020-10-13	19.06
2020-10-12	18.83
2020-10-09	18.19
2020-10-08	19.22
2020-10-07	19.24
2020-10-06	19.30
2020-10-05	19.52
2020-10-02	19.72
2020-10-01	23.06
2020-09-30	26.02
2020-09-29	24.83
2020-09-28	23.49
2020-09-25	22.87
2020-09-24	21.17
2020-09-23	22.00
2020-09-22	22.84
2020-09-21	23.07
2020-09-18	25.86
2020-09-17	23.63
2020-09-16	22.46
2020-09-15	22.08
2020-09-14	23.26
2020-09-11	22.22
2020-09-10	21.13
2020-09-09	19.84
2020-09-08	19.32
2020-09-04	18.84
2020-09-03	18.99
2020-09-02	21.22
2020-09-01	20.32
2020-08-31	17.44
2020-08-28	17.67
2020-08-27	16.71
2020-08-26	17.14
2020-08-25	17.08
2020-08-24	17.54
2020-08-21	20.02
2020-08-20	21.04
2020-08-19	21.77
2020-08-18	20.67
2020-08-17	20.12
2020-08-14	17.80
2020-08-13	18.61
2020-08-12	13.59
2020-08-11	11.96
2020-08-10	13.22
2020-08-07	13.59
2020-08-06	13.13
2020-08-05	13.04
2020-08-04	13.85
2020-08-03	14.25
2020-07-31	14.45
2020-07-30	14.19
2020-07-29	14.36
2020-07-28	14.11
2020-07-27	14.59
2020-07-24	14.17

Price/FCF Ratio: N/A

NRIX Price/FCF Ratio Chart

NRIX Price/FCF Ratio Metrics

NRIX Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

NRIX Price/FCF Ratio History

Related Metrics